サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1530408

がん治療施設の市場規模、シェア、動向分析レポート：治療別、がんタイプ別、プロバイダー別、地域別、セグメント別予測、2024年～2030年

Cancer Treatment Facilities Market Size, Share, & Trends Analysis Report By Treatment (Cancer Surgery, Chemotherapy), By Cancer Type (Blood Cancer, Breast Cancer), By Provider, By Region, And Segment Forecasts, 2024 - 2030

出版日
ページ情報
英文 90 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
がん治療施設の市場規模、シェア、動向分析レポート：治療別、がんタイプ別、プロバイダー別、地域別、セグメント別予測、2024年～2030年
出版日: 2024年07月23日
発行: Grand View Research
ページ情報: 英文 90 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

がん治療施設市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界のがん治療施設市場規模は2030年までに787億1,000万米ドルに達すると予測され、予測期間中のCAGRは7.75%で成長すると予測されています。

市場成長の主な促進要因としては、患者支援プログラムの増加、がん啓発のための政府の取り組み、個別化医療に対する需要の増加などが挙げられます。

世界中の女性の間で乳がんなどの新生物の有病率が増加していることから、ヘルスケアプロバイダーにとって乳がんは重要な専門分野であり、投資対象でもあります。高度な診断技術、個別化医療、オーダーメイドの治療アプローチに対する需要は、患者の転帰と生存率を高め、予測期間中の同分野の成長を牽引すると期待されています。例えば、2024年1月、MGMヘルスケアはクリニックBを開設し、良性のしこりや嚢胞から腫瘍や再建に至るまで、あらゆる種類の乳房の健康問題に対する包括的かつ高度な治療で患者を支援・サポートしています。

さらに、免疫療法は近年、ある種のがんの治療において重要な位置を占めるようになっています。免疫療法は、がんに特異的な標的に免疫系を向けることによって、がんと闘う免疫系の能力を高めることができるため、存在感を増している先進的な治療法です。このため、サービスプロバイダーは、市場での存在感を高めるための戦略的イニシアチブを強めており、これが今後数年間の成長の原動力になると予想されます。2023年1月、BioNTech SEは英国政府と協力し、2030年末までに最大10,000人の患者に改変mRNA免疫療法の臨床試験を提供します。さらに、感染症ワクチンの提供や、英国市場での足跡を増やすための投資にも注力しています。

さらに、いくつかの業界プレーヤーは、浸透度を高めるために新しいサービスを開始しています。例えば、2024年3月、Tampa General HospitalはTampaのメインキャンパスでTGH Cancer Institute Phase I Cancer Research Unitを開始しました。このPhase I Cancer Research Unitの目的は、がん患者に思いやりのある包括的ケアと統合された最先端の調査研究へのアクセスを提供することです。

がん治療施設市場レポートハイライト：

  • 治療に関しては、がん手術部門が2023年の売上高シェア34.12%で市場を独占しました。ロボット手術技術の開発と採用の増加が、同分野の成長に大きな影響を与えています。しかし、予測期間中は化学療法サービスが最も急成長しています。
  • がんの種類に基づくと、血液がんセグメントは2023年に最大の収益シェアを占めました。この成長は、血液がん治療の研究開発への主要企業の関与が世界的に増加していることに起因しています。
  • 提供者に基づくと、病院セグメントは、腫瘍科における高度な診断および治療能力により、2023年に最大の収益シェアを占めました。
  • アジア太平洋地域は、がん罹患率の増加、個別化医療に対する需要の増加、ヘルスケアインフラの整備の増加などの要因により、2023年に市場を独占しました。
  • 2024年5月、HCG（ヘルスケア・世界・エンタープライズ）は北ベンガルールに新しいがん治療センターを開設し、合計125床を追加しました。戦略的に配置されたこれらの施設では、診断から個別化された治療計画まで、高度ながん治療を全面的に提供します。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 市場の変数、動向、範囲

  • 市場系統の見通し
  • 市場力学
    • 市場 促進要因分析
    • 市場抑制要因分析
  • ビジネス環境分析
    • ポーターのファイブフォース分析
    • PESTLE分析

第4章 がん治療施設市場：治療別推定・動向分析

  • 治療別市場シェア、2023年と2030年
  • 治療別セグメントダッシュボード
  • 治療別市場規模と予測および動向分析、2018年から2030年
  • 骨髄移植
  • 化学療法
  • 放射線治療
  • ホルモン療法
  • 免疫療法
  • がん手術

第5章 がん治療施設市場：がんタイプ別推定・動向分析

  • がんタイプ別市場シェア、2023年および2030年
  • がんタイプ別セグメントダッシュボード
  • がんタイプ別の市場規模と予測および動向分析、2018年から2030年
  • 血液がん
  • 乳がん
  • 前立腺がん
  • 消化器がん
  • 婦人科がん
  • 呼吸器/肺がん
  • その他のがんタイプ

第6章 がん治療施設市場：プロバイダー別推定・動向分析

  • プロバイダー別市場シェア、2023年および2030年
  • プロバイダー別セグメントダッシュボード
  • プロバイダー別市場規模と予測および動向分析、2018～2030年
  • がんセンター
  • 病院

第7章 がん治療施設市場：地域別推定・動向分析

  • 地域別市場シェア分析、2023年および2030年
  • 地域市場ダッシュボード
  • 市場規模と予測動向分析、2018年から2030年
  • 北米
    • 北米のがん治療施設市場推計・予測、2018年-2030年
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 欧州のがん治療施設市場推計・予測、2018年-2030年
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • デンマーク
    • スウェーデン
    • ノルウェー
  • アジア太平洋
    • アジア太平洋地域のがん治療施設市場推計・予測、2018年-2030年
    • 日本
    • 中国
    • インド
    • 韓国
    • オーストラリア
    • タイ
  • ラテンアメリカ
    • ラテンアメリカのがん治療施設市場推計・予測、2018年-2030年
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 中東・アフリカがん治療施設市場推計・予測、2018-2030
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第8章 競合情勢

  • 参加者概要
  • 企業の市況分析
  • 企業分類
  • 戦略マッピング
  • 企業プロファイル/リスト
    • Compass Oncology
    • American Oncology Institute
    • Mayo Foundation for Medical Education and Research（MFMER）
    • HCA International Limited
    • The Royal Marsden
    • National Cancer Instituteat the National Institutes of Health
    • Apollo Hospitals Enterprise Ltd.
    • Kokilaben Dhirubhai Ambani Hospital
    • HEALTHCARE GLOBAL ENTERPRISES LIMITED
    • The Johns Hopkins Hospital
    • Tata Memorial Centre.
図表

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
  • Table 4 Global cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
  • Table 5 Global cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
  • Table 6 Global cancer treatment facilities market, by region, 2018 - 2030 (USD Million)
  • Table 7 North America cancer treatment facilities market, by country, 2018 - 2030 (USD Million)
  • Table 8 North America cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
  • Table 9 North America cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
  • Table 10 North America cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
  • Table 11 U.S. cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
  • Table 12 U.S. cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
  • Table 13 U.S. cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
  • Table 14 Canada cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
  • Table 15 Canada cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
  • Table 16 Canada cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
  • Table 17 Mexico cancer treatment facilities market, by teatment, 2018 - 2030 (USD Million)
  • Table 18 Mexico cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
  • Table 19 Mexico cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
  • Table 20 Europe cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
  • Table 21 Europe cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
  • Table 22 Europe cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
  • Table 23 UK cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
  • Table 24 UK cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
  • Table 25 UK cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
  • Table 26 Germany cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
  • Table 27 Germany cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
  • Table 28 Germany cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
  • Table 29 France cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
  • Table 30 France cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
  • Table 31 France cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
  • Table 32 Italy cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
  • Table 33 Italy cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
  • Table 34 Italy cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
  • Table 35 Spain cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
  • Table 36 Spain cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
  • Table 37 Spain cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
  • Table 38 Norway cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
  • Table 39 Norway cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
  • Table 40 Norway cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
  • Table 41 Sweden cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
  • Table 42 Sweden cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
  • Table 43 Sweden cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
  • Table 44 Denmark cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
  • Table 45 Denmark cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
  • Table 46 Denmark cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific cancer treatment facilities market, by country, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
  • Table 51 Japan cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
  • Table 52 Japan cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
  • Table 53 Japan cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
  • Table 54 China cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
  • Table 55 China cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
  • Table 56 China cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
  • Table 57 India cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
  • Table 58 India cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
  • Table 59 India cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
  • Table 60 Australia cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
  • Table 61 Australia cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
  • Table 62 Australia cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
  • Table 63 South Korea cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
  • Table 64 South Korea cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
  • Table 65 South Korea cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
  • Table 66 Thailand cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
  • Table 67 Thailand cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
  • Table 68 Thailand cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
  • Table 69 Latin America cancer treatment facilities market, by country, 2018 - 2030 (USD Million)
  • Table 70 Latin America cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
  • Table 71 Latin America cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
  • Table 72 Latin America cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
  • Table 73 Brazil cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
  • Table 74 Brazil cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
  • Table 75 Brazil cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
  • Table 76 Argentina cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
  • Table 77 Argentina cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
  • Table 78 Argentina cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
  • Table 79 Middle East & Africa cancer treatment facilities market, by country, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
  • Table 83 South Africa cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
  • Table 84 South Africa cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
  • Table 85 South Africa cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
  • Table 86 Saudi Arabia cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
  • Table 89 UAE cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
  • Table 90 UAE cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
  • Table 91 UAE cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
  • Table 92 Kuwait cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
  • Table 93 Kuwait cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
  • Table 94 Kuwait cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 Market segmentation
  • Fig. 8 Market snapshot
  • Fig. 9 Segment snapshot
  • Fig. 10 Competitive landscape snapshot
  • Fig. 11 Market trends & outlook
  • Fig. 12 Market driver relevance analysis (current & future impact)
  • Fig. 13 Market restraint relevance analysis (current & future impact)
  • Fig. 14 PESTLE analysis
  • Fig. 15 Porter's five forces analysis
  • Fig. 16 Cancer treatment facilities market: Treatment outlook and key takeaways
  • Fig. 17 Cancer treatment facilities market: Treatment movement analysis
  • Fig. 18 Bone marrow transplantation market revenue, 2018 - 2030 (USD Million)
  • Fig. 19 Chemotherapy market revenue, 2018 - 2030 (USD Million)
  • Fig. 20 Radiation therapy market revenue, 2018 - 2030 (USD Million)
  • Fig. 21 Hormone therapy market revenue, 2018 - 2030 (USD Million)
  • Fig. 22 Immunotherapy market revenue, 2018 - 2030 (USD Million)
  • Fig. 23 Cancer surgery market revenue, 2018 - 2030 (USD Million)
  • Fig. 24 Cancer treatment facilities market: Cancer type outlook and key takeaways
  • Fig. 25 Cancer treatment facilities market: Cancer type movement analysis
  • Fig. 26 Blood cancer market revenue, 2018 - 2030 (USD Million)
  • Fig. 27 Breast cancer market revenue, 2018 - 2030 (USD Million)
  • Fig. 28 Prostate cancer market revenue, 2018 - 2030 (USD Million)
  • Fig. 29 Gastrointestinal cancer market revenue, 2018 - 2030 (USD Million)
  • Fig. 30 Gynecologic cancer market revenue, 2018 - 2030 (USD Million)
  • Fig. 31 Respiratory/Lung cancer market revenue, 2018 - 2030 (USD Million)
  • Fig. 32 Other cancer types market revenue, 2018 - 2030 (USD Million)
  • Fig. 33 Cancer treatment facilities market: Provider outlook and key takeaways
  • Fig. 34 Cancer treatment facilities market: Provider movement analysis
  • Fig. 35 Cancer centers market revenue, 2018 - 2030 (USD Million)
  • Fig. 36 Hospitals market revenue, 2018 - 2030 (USD Million)
  • Fig. 37 Regional marketplace: Key takeaways
  • Fig. 38 Regional outlook, 2023 & 2030
  • Fig. 39 Cancer treatment facilities market: Region movement analysis
  • Fig. 40 North America cancer treatment facilities market, 2018-2030, (USD Million)
  • Fig. 41 US key country dynamics
  • Fig. 42 US cancer treatment facilities market, 2018 - 2030 (USD Million)
  • Fig. 43 Canada key country dynamics
  • Fig. 44 Canada cancer treatment facilities market, 2018 - 2030 (USD Million)
  • Fig. 45 Mexico key country dynamics
  • Fig. 46 Mexico cancer treatment facilities market, 2018 - 2030 (USD Million)
  • Fig. 47 Europe cancer treatment facilities market, 2018 - 2030 (USD Million)
  • Fig. 48 UK key country dynamic
  • Fig. 49 UK cancer treatment facilities market, 2018 - 2030 (USD Million)
  • Fig. 50 Germany key country dynamic
  • Fig. 51 Germany cancer treatment facilities market, 2018 - 2030 (USD Million)
  • Fig. 52 France key country dynamic
  • Fig. 53 France cancer treatment facilities market, 2018 - 2030 (USD Million)
  • Fig. 54 Italy key country dynamic
  • Fig. 55 Italy cancer treatment facilities market, 2018 - 2030 (USD Million)
  • Fig. 56 Spain key country dynamic
  • Fig. 57 Spain cancer treatment facilities market, 2018 - 2030 (USD Million)
  • Fig. 58 Denmark key country dynamic
  • Fig. 59 Denmark cancer treatment facilities market, 2018 - 2030 (USD Million)
  • Fig. 60 Sweden key country dynamic
  • Fig. 61 Sweden cancer treatment facilities market, 2018 - 2030 (USD Million)
  • Fig. 62 Norway key country dynamic
  • Fig. 63 Norway cancer treatment facilities market, 2018 - 2030 (USD Million)
  • Fig. 64 Asia Pacific cancer treatment facilities market, 2018 - 2030 (USD Million)
  • Fig. 65 China key country dynamic
  • Fig. 66 China cancer treatment facilities market, 2018 - 2030 (USD Million)
  • Fig. 67 Japan key country dynamic
  • Fig. 68 Japan cancer treatment facilities market, 2018 - 2030 (USD Million)
  • Fig. 69 India key country dynamic
  • Fig. 70 India cancer treatment facilities market, 2018 - 2030 (USD Million)
  • Fig. 71 South Korea key country dynamic
  • Fig. 72 South Korea cancer treatment facilities market, 2018 - 2030 (USD Million)
  • Fig. 73 Australia key country dynamic
  • Fig. 74 Australia cancer treatment facilities market, 2018 - 2030 (USD Million)
  • Fig. 75 Thailand key country dynamic
  • Fig. 76 Thailand cancer treatment facilities market, 2018 - 2030 (USD Million)
  • Fig. 77 Latin America cancer treatment facilities market, 2018 - 2030 (USD Million)
  • Fig. 78 Brazil key country dynamic
  • Fig. 79 Brazil cancer treatment facilities market, 2018 - 2030 (USD Million)
  • Fig. 80 Argentina key country dynamic
  • Fig. 81 Argentina cancer treatment facilities market, 2018 - 2030 (USD Million)
  • Fig. 82 MEA cancer treatment facilities market, 2018 - 2030 (USD Million)
  • Fig. 83 South Africa key country dynamic
  • Fig. 84 South Africa cancer treatment facilities market, 2018 - 2030 (USD Million)
  • Fig. 85 Saudi Arabia key country dynamic
  • Fig. 86 Saudi Arabia cancer treatment facilities market, 2018 - 2030 (USD Million)
  • Fig. 87 UAE key country dynamic
  • Fig. 88 UAE cancer treatment facilities market, 2018 - 2030 (USD Million)
  • Fig. 89 Kuwait key country dynamic
  • Fig. 90 Kuwait cancer treatment facilities market, 2018 - 2030 (USD Million)
  • Fig. 91 Company categorization
  • Fig. 92 Strategy mapping
  • Fig. 93 Company market position analysis
目次
Product Code: GVR-4-68040-374-3

Cancer Treatment Facilities Market Growth & Trends:

The global cancer treatment facilities market size is anticipated to reach USD 78.71 billion by 2030 and is anticipated to grow at a CAGR of 7.75% over the forecast period, according to a new report by Grand View Research, Inc. Key drivers of market growth include increasing patient assistance programs, government initiatives for cancer awareness, and the increasing demand for personalized medicine.

The increasing prevalence of neoplasm, such as breast cancer, among women worldwide makes it a significant area of specialization and investment for healthcare providers. The demand for advanced diagnostic technologies, personalized medicine, and tailored treatment approaches enhances patient outcomes and survival rates and is expected to drive the growth of the segment during the forecast period. For instance, in January 2024, MGM Healthcare launched Clinic B to support and help patients with comprehensive and advanced treatment for all types of breast health problems - ranging from benign lumps and cysts to tumors and reconstruction.

Furthermore, immunotherapy has become an important part of treating some types of cancer in recent years. Immunotherapy is an advanced type of treatment that is growing its presence due to its ability to enhance the immune system's ability to fight cancer by directing it toward cancer-specific targets; this leads to growing strategic initiatives by the service providers to grow its presence in the market, which is expected to drive the growth in the coming years. In January 2023, BioNTech SE collaborated with the UK government to provide clinical trials for modified mRNA immunotherapies for up to 10,000 patients by the end of 2030. In addition, it is focused on offering infectious disease vaccines and investment to increase its footprint in the UK market.

Furthermore, several industry players are launching new services to improve their penetration. For instance, in March 2024, Tampa General Hospital commenced the TGH Cancer Institute Phase I Cancer Research Unit at the main campus in Tampa. The aim of this Phase I Cancer Research Unit is to provide cancer patients with access to leading-edge research studies integrated with compassionate and comprehensive care.

Cancer Treatment Facilities Market Report Highlights:

  • In terms of treatment, the cancer surgery segment dominated the market with a revenue share of 34.12% in 2023. The development and increasing adoption of robotic surgery techniques is having a significant impact on the growth of the segment. However, chemotherapy services are the fastest-growing segment during the forecast period.
  • Based on the cancer type, the blood cancer segment accounted for the maximum revenue share in 2023. This growth is attributed to the increasing involvement of key companies in the R&D of blood cancer treatments globally.
  • Based on provider, the hospital segment accounted for the maximum revenue share in 2023 due to its advanced diagnostic and treatment capabilities in oncology departments.
  • Asia Pacific dominated the market in 2023 due to factors such as the growing cancer incidence, increasing demand for personalized care, and the rise in the development of healthcare infrastructure.
  • In May 2024, HCG (Healthcare Global Enterprises) opened new cancer care centers in North Bengaluru, adding a total of 125 beds. These strategically positioned facilities will provide a complete range of advanced cancer treatments, from diagnosis to personalized treatment plans.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Treatment
    • 1.2.2. Cancer Type
    • 1.2.3. Provider
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Volume Price Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing incidence of cancers
      • 3.2.1.2. Technology advancement
      • 3.2.1.3. Rising medical tourism
      • 3.2.1.4. Growing government investment in cancer treatment facility
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High initial investment cost to setup cancer treatment facility
      • 3.2.2.2. Stringent regulations for cancer treatment facility setup
  • 3.3. Business Environment Analysis
    • 3.3.1. Porter's Five Forces Analysis
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. Cancer Treatment Facilities Market: Treatment Estimates & Trend Analysis

  • 4.1. Treatment Market Share, 2023 & 2030
  • 4.2. Treatment Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Treatment, 2018 to 2030 (USD Million)
  • 4.4. Bone Marrow Transplantation
    • 4.4.1. Bone marrow transplantation market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.5. Chemotherapy
    • 4.5.1. Chemotherapy market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.6. Radiation Therapy
    • 4.6.1. Radiation therapy market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.7. Hormone Therapy
    • 4.7.1. Hormone therapy market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.8. Immunotherapy
    • 4.8.1. Immunotherapy market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.9. Cancer Surgery
    • 4.9.1. Cancer surgery market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 5. Cancer Treatment Facilities Market: Cancer Type Estimates & Trend Analysis

  • 5.1. Cancer Type Market Share, 2023 & 2030
  • 5.2. Cancer Type Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analyses, by Cancer type, 2018 to 2030 (USD Million)
  • 5.4. Blood Cancer
    • 5.4.1. Blood cancer market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.5. Breast Cancer
    • 5.5.1. Breast cancer market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.6. Prostate Cancer
    • 5.6.1. Prostate cancer market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.7. Gastrointestinal Cancer
    • 5.7.1. Gastrointestinal cancer market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.8. Gynecologic Cancer
    • 5.8.1. Gynecologic cancer market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.9. Respiratory/Lung Cancer
    • 5.9.1. Respiratory/Lung cancer market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.10. Other Cancer Types
    • 5.10.1. Other cancer types market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 6. Cancer Treatment Facilities Market: Provider Estimates & Trend Analysis

  • 6.1. Provider Market Share, 2023 & 2030
  • 6.2. Provider Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analyses, by Provider, 2018 to 2030 (USD Million)
  • 6.4. Cancer Centers
    • 6.4.1. Cancer centers market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.5. Hospitals
    • 6.5.1. Hospitals market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 7. Cancer Treatment Facilities Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2023 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030
  • 7.4. North America
    • 7.4.1. North America cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key country dynamic
      • 7.4.2.2. Regulatory framework
      • 7.4.2.3. Competitive insights
      • 7.4.2.4. U.S. cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key country dynamic
      • 7.4.3.2. Regulatory framework
      • 7.4.3.3. Competitive insights
      • 7.4.3.4. Canada cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. Mexico
      • 7.4.4.1. Key country dynamic
      • 7.4.4.2. Regulatory framework
      • 7.4.4.3. Competitive insights
      • 7.4.4.4. Mexico cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. Europe cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. Germany
      • 7.5.2.1. Key country dynamic
      • 7.5.2.2. Regulatory framework
      • 7.5.2.3. Competitive insights
      • 7.5.2.4. Germany cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. UK
      • 7.5.3.1. Key country dynamic
      • 7.5.3.2. Regulatory framework
      • 7.5.3.3. Competitive insights
      • 7.5.3.4. UK cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key country dynamic
      • 7.5.4.2. Regulatory framework
      • 7.5.4.3. Competitive insights
      • 7.5.4.4. France cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key country dynamic
      • 7.5.5.2. Regulatory framework
      • 7.5.5.3. Competitive insights
      • 7.5.5.4. Italy cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key country dynamic
      • 7.5.6.2. Regulatory framework
      • 7.5.6.3. Competitive insights
      • 7.5.6.4. Spain cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.7. Denmark
      • 7.5.7.1. Key country dynamic
      • 7.5.7.2. Regulatory framework
      • 7.5.7.3. Competitive insights
      • 7.5.7.4. Denmark cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.8. Sweden
      • 7.5.8.1. Key country dynamic
      • 7.5.8.2. Regulatory framework
      • 7.5.8.3. Competitive insights
      • 7.5.8.4. Sweden cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.9. Norway
      • 7.5.9.1. Key country dynamic
      • 7.5.9.2. Regulatory framework
      • 7.5.9.3. Competitive insights
      • 7.5.9.4. Norway cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key country dynamic
      • 7.6.2.2. Regulatory framework
      • 7.6.2.3. Competitive insights
      • 7.6.2.4. Japan cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key country dynamic
      • 7.6.3.2. Regulatory framework
      • 7.6.3.3. Competitive insights
      • 7.6.3.4. China cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key country dynamic
      • 7.6.4.2. Regulatory framework
      • 7.6.4.3. Competitive insights
      • 7.6.4.4. India cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. South Korea
      • 7.6.5.1. Key country dynamic
      • 7.6.5.2. Regulatory framework
      • 7.6.5.3. Competitive insights
      • 7.6.5.4. South Korea cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.6.6. Australia
      • 7.6.6.1. Key country dynamic
      • 7.6.6.2. Regulatory framework
      • 7.6.6.3. Competitive insights
      • 7.6.6.4. Australia cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Key country dynamic
      • 7.6.7.2. Regulatory framework
      • 7.6.7.3. Competitive insights
      • 7.6.7.4. Thailand cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key country dynamic
      • 7.7.2.2. Regulatory framework
      • 7.7.2.3. Competitive insights
      • 7.7.2.4. Brazil cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key country dynamic
      • 7.7.3.2. Regulatory framework
      • 7.7.3.3. Competitive insights
      • 7.7.3.4. Argentina cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.8. MEA
    • 7.8.1. MEA cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key country dynamic
      • 7.8.2.2. Regulatory framework
      • 7.8.2.3. Competitive insights
      • 7.8.2.4. South Africa cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key country dynamic
      • 7.8.3.2. Regulatory framework
      • 7.8.3.3. Competitive insights
      • 7.8.3.4. Saudi Arabia cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key country dynamic
      • 7.8.4.2. Regulatory framework
      • 7.8.4.3. Competitive insights
      • 7.8.4.4. UAE cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key country dynamic
      • 7.8.5.2. Regulatory framework
      • 7.8.5.3. Competitive insights
      • 7.8.5.4. Kuwait cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Participant Overview
  • 8.2. Company Market Position Analysis
  • 8.3. Company Categorization
  • 8.4. Strategy Mapping
  • 8.5. Company Profiles/Listing
    • 8.5.1. Compass Oncology
      • 8.5.1.1. Overview
      • 8.5.1.2. Financial performance
      • 8.5.1.3. Service benchmarking
      • 8.5.1.4. Strategic initiatives
    • 8.5.2. American Oncology Institute
      • 8.5.2.1. Overview
      • 8.5.2.2. Financial performance
      • 8.5.2.3. Service benchmarking
      • 8.5.2.4. Strategic initiatives
    • 8.5.3. Mayo Foundation for Medical Education and Research (MFMER)
      • 8.5.3.1. Overview
      • 8.5.3.2. Financial performance
      • 8.5.3.3. Service benchmarking
      • 8.5.3.4. Strategic initiatives
    • 8.5.4. HCA International Limited
      • 8.5.4.1. Overview
      • 8.5.4.2. Financial performance
      • 8.5.4.3. Service benchmarking
      • 8.5.4.4. Strategic initiatives
    • 8.5.5. The Royal Marsden
      • 8.5.5.1. Overview
      • 8.5.5.2. Financial performance
      • 8.5.5.3. Service benchmarking
      • 8.5.5.4. Strategic initiatives
    • 8.5.6. National Cancer Instituteat the National Institutes of Health
      • 8.5.6.1. Overview
      • 8.5.6.2. Financial performance
      • 8.5.6.3. Service benchmarking
      • 8.5.6.4. Strategic initiatives
    • 8.5.7. Apollo Hospitals Enterprise Ltd.
      • 8.5.7.1. Overview
      • 8.5.7.2. Financial performance
      • 8.5.7.3. Service benchmarking
      • 8.5.7.4. Strategic initiatives
    • 8.5.8. Kokilaben Dhirubhai Ambani Hospital
      • 8.5.8.1. Overview
      • 8.5.8.2. Financial performance
      • 8.5.8.3. Service benchmarking
      • 8.5.8.4. Strategic initiatives
    • 8.5.9. HEALTHCARE GLOBAL ENTERPRISES LIMITED
      • 8.5.9.1. Overview
      • 8.5.9.2. Financial performance
      • 8.5.9.3. Service benchmarking
      • 8.5.9.4. Strategic initiatives
    • 8.5.10. The Johns Hopkins Hospital
      • 8.5.10.1. Overview
      • 8.5.10.2. Financial performance
      • 8.5.10.3. Service benchmarking
      • 8.5.10.4. Strategic initiatives
    • 8.5.11. Tata Memorial Centre.
      • 8.5.11.1. Overview
      • 8.5.11.2. Financial performance
      • 8.5.11.3. Service benchmarking
      • 8.5.11.4. Strategic initiatives